Insights into extending the longevity and survial of Haematopoietic stem cells: The epithelial-mesenchymal transition protein Snai1/Snail1 increases the longevity of hematopoietic stem cells via up regulation of its target gene, Genome-2-Bio-Medicine Discovery Center, 08/July/2014, 7.23 am

Anti-miRNA based therapy for NIDDM: Increased expression of Stress-responsive MiRNA-9 promotes gluconeogenesis and hyperglycemia via down regulation of Cyclin D1, Genome-2-Bio-Medicine Discovery center (GBMD), 8/07/2014, 6.08 am
July 8, 2014
MiRNAs-based therapy for Cardiovascular and metabolic disorders: MiRNA-138 improves cardiovascular and metabolic abnormalities via down regulation of its target gene, 8/July/2014, 7.30 am
July 8, 2014
Show all

Noble laureate in Physiology/Medicine (1975) Prof. David Baltimore, from California Institute of Technology, California, USA, had reported in the journal Elife that “MiRNA-146a acts as a guardian of the quality and longevity of hematopoietic stem cells in mice.”

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Insights into extending the longevity and survial of Haematopoietic stem cells: The epithelial-mesenchymal transition protein Snai1/Snail1  increases the longevity of hematopoietic stem cells via up regulation of its target gene.  

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan,  Insights into extending the longevity and survial of Haematopoietic stem cells: The epithelial-mesenchymal transition protein Snai1/Snail1 increases the longevity of hematopoietic stem cells via up regulation of its target gene,  Genome-2-Bio-Medicine Discovery Center, 08/July/2014, 7.23 am

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.